Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Various Advanced Cancer × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 84 Neoplasms 67 Prostatic Neoplasms 40 Carcinoma, Non-Small-Cell Lung 32 Melanoma 27 Colorectal Neoplasms 24 Brain Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 15 Neoplasm Metastasis 15 Lung Neoplasms 15 Pancreatic Neoplasms 14 Head and Neck Neoplasms 14 Recurrence 13 Ovarian Neoplasms 13 Multiple Myeloma 13 Glioma 13 Carcinoma, Hepatocellular 13 Uterine Cervical Neoplasms 12 Urinary Bladder Neoplasms 12 Sarcoma 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Hematologic Neoplasms 11 Colonic Neoplasms 11 Lymphoma 10 Esophageal Neoplasms 10 Stomach Neoplasms 9 Lymphoma, Follicular 9 Leukemia, Myeloid, Acute 9 Gastrointestinal Neoplasms 9 Cholangiocarcinoma 9

Interventions

Nivolumab 1 Ipilimumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡